Product Information
Registration Status: ActiveSIN13743P
ROTARIX ORAL SUSPENSION (ORAL APPLICATOR) is approved to be sold in Singapore with effective from 2009-04-12. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN13743P.
This product contains Human Rotavirus Not less than 10 CCID?/dose (1.5ml) in the form of SUSPENSION. It is approved for ORAL use.
This product is manufactured by GlaxoSmithKline Biologicals s.a.
GlaxoSmithKline Biologicals s.a. (Filling) in BELGIUM.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.